Evaluation of Respiratory Function During Self-induced Cognitive Trance
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 9
- Locations
- 1
- Primary Endpoint
- FEV during a state of self-induced cognitive trance
Study Overview
Brief Summary
The goal of this Prospective, monocentric, non-randomized, open-label study aimed at evaluating the variation of FEV1 during a state of self-induced cognitive trance participant population: Person with expertise in the practice of TCAI can be inclued. (at least 6 months, in order to be able to control the depth of the trance and to have a motor control allowing the realization of a spirometry)
The main question:
Study the significant variation of FEV1 before, during, or after the state of self-induced cognitive trance
Detailed Description
Primary objective : Study the significant variation of FEV1 before, during, or after the state of self-induced cognitive trance judgment criteria:
Significant variations in:
PEF PEF25 PEF50 PEF75 FVC Inspiratory capacity, SpO2 Respiratory rate before, during, or after the self-induced cognitive trance state Evolution of the feeling of self-efficacy, assessed by questionnaire
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Basic Science
- Masking
- None
Masking Description
Person with expertise in the practice of TCAI. (at least 6 months, in order to be able to control the depth of the trance and to have a motor control allowing the realization of a spirometry)
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Person over 18 years old
- •Person with expertise in the practice of TCAI. (at least 6 months, in order to be able to control the depth of the trance and to have a motor control allowing the realization of a spirometry)
- •Person affiliated with social security or beneficiary of such a scheme.
- •Person having given, in writing, their free and informed consent to participate in the study
Exclusion Criteria
- •Person deprived of liberty by judicial or administrative decision, person subject to a measure of legal protection.
- •Exclusion period for other studies
- •Person likely, according to the investigator's assessment, not to be cooperative or respectful of the obligations inherent in participation in the study
- •Person with a psychiatric, neurological or cardiovascular disease.
- •Person with a chronic respiratory disease, for example: asthma, COPD, interstitial lung disease, bronchial dilation, cystic fibrosis,
- •Person with a history of exercise-induced bronchospasm.
- •Person taking inhaled treatments (corticotherapy, bronchodilators, anticholinergics)
- •Pregnant woman (declarative).
Arms & Interventions
Interventionnal
Measure DEP, DEM25, DEM 50, DEM 75, FVC, Inspiratory capacity, SpO2, Respiratory rate before, during, or after the state of self-induced cognitive trance Evolution of the feeling of self-efficacy, assessed by questionnaire.
Intervention: spirometry (Diagnostic Test)
Outcomes
Primary Outcomes
FEV during a state of self-induced cognitive trance
Time Frame: 3 month
variation of forced exhaled volume in one second between pre and post phase of cognitive transe
Secondary Outcomes
- PEF during a state of self-induced cognitive trance(3 month)
- inspiratory capacity during a state of self-induced cognitive trance(3 month)
- respiratory rate during a state of self-induced cognitive trance(3 month)
- DEM25/50/75 during a state of self-induced cognitive trance(3 month)
- SpO2 during a state of self-induced cognitive trance(3 month)
- FVC during a state of self-induced cognitive trance(3 month)